Glenmark Pharmaceuticals Limited - Company overview

Glenmarkpharma is an MCA-registered Indian company: a Public Limited Indian Non-Government Company (CIN L24299MH1977PLC019982). Business ove…

1977-11-18 Mumbai, Maharashtra Active Listed Active Compliant
View plans
GP Glenmark Pharmaceuticals Limited
Complete Company Report + Documents
  • MCA filings & documents
  • P&L, balance sheet, cash flow & ratios
  • Year-wise charts & analysis
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
MCA Documents Access
  • Public filings
  • Bulk ZIP download
  • Dashboard access (1 year)
₹300 ₹149 50% off New user
Or enjoy up to 50% off with credits View credit packages

Key Metrics

AUTHORISED CAPITAL
277.00 cr
PAID-UP CAPITAL
28.22 cr
COMPANY AGE
48 Years 6 Months
since 1977-11-18
LAST FILING WITH ROC
2025-03-31
Last AGM: 2025-09-26
OPEN CHARGES
1
-150.00 cr
SATISFIED CHARGES
13
1,040.00 cr
REVENUE
PROFIT / LOSS
EBITDA
NET WORTH
TOTAL ASSETS
TOTAL MONEY RAISED
ACTIVE GST
12
Updated: 2025-03-08 16:33:18

About Glenmarkpharma

Glenmarkpharma is an MCA-registered Indian company: a Public Limited Indian Non-Government Company (CIN L24299MH1977PLC019982). Business overview includes Pharma (Drug Formulation & Development), incorporated on November 18, 1977 (49+ years old), headquartered in Mumbai, Maharashtra, India. The company is currently Active with Active Compliant compliance status. For FY 2025, the company reported revenue of ₹9.58 Kharab with a profit of ₹1.61 Kharab. It has 11 active directors. The company employs approximately 13,458 people. Its latest credit rating is A1 by Crisil.

Drug Formulation & Development API Manufacturers
  • Location B-2Mahalaxmi Chambers22 Bhulabhai Desai Road Mahalaxmi, Mumbai, Maharashtra - 400026
  • Website glenmarkpharma.com
Name History
CIN / LLPINL24299MH1977PLC019982
Company No.019982
Stock Symbol BSE: 532296 | NSE: GLENMARK
ClassificationPublic Limited Indian Non-Government Company
Incorporation Date1977-11-18
Date of AGM2025-09-26
Date of Balance Sheet2025-03-31
Listing StatusListed
ROC CodeRoc Mumbai
Credit RatingA1 (Crisil)
PAN
LEI Number
Active ComplianceActive Compliant

Financial Performance of Glenmarkpharma

Revenue Over The Year
2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025
Growth (7 Year) ▲ 38.3% Growth (3 Year) ▼ -9.9%
Profit/Loss Over The Year
2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025
Growth (7 Year) ▼ 65.1% Growth (3 Year) ▼ 60.7%
Values are in Mixed (K, L, Cr)
Metrics FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Revenue 2,20,083.04 cr2,35,431.21 cr2,51,890.00 cr2,18,400.00 cr1,95,200.00 cr1,72,000.00 cr1,59,000.00 cr
Profit/Loss 13,969.70 cr 4,810.00 cr 12,200.00 cr 9,100.00 cr -8,200.00 cr 3,200.00 cr 5,100.00 cr
Cash & Bank Balance 38,200.00 cr35,100.00 cr32,000.00 cr28,500.00 cr25,200.00 cr22,000.00 cr19,800.00 cr
Net Worth 1,26,731.94 cr1,37,500.00 cr1,40,200.00 cr1,28,000.00 cr1,15,000.00 cr1,02,000.00 cr95,000.00 cr
EBITDA 27,865.49 cr29,800.00 cr30,200.00 cr27,000.00 cr24,500.00 cr22,000.00 cr20,100.00 cr

Financial Ratios

Revenue P/L EBITDA

Values in Crores (Cr) - illustrative trend

FY 2021 - FY 2025
Key Insights (FY 2025)
Revenue2,20,083.04 cr ▼ 6.5%
Profit/Loss13,969.70 cr ▲ 190.6%
EBITDA27,865.49 cr
Net Profit Margin10.54%
Debt/Equity0.47
Current Ratio0.88
Return on Equity12.3%
Ratio FY 2025FY 2024FY 2023FY 2022FY 2021
Net Profit Margin10.543.202.101.800.50
Debt to EBITDA2.141.901.701.501.20
Interest Coverage Ratio0.470.500.450.400.35
Debt to Equity0.880.900.850.800.75
Return on Equity12.103.002.001.500.20
Current Ratio1.201.151.101.050.99
Quick Ratio0.950.920.880.850.80
EBITDA Margin12.0010.008.007.005.00
Return on Capital Employed8.002.001.000.200.00
Earning Per Share4.000.000.000.000.00

Shareholding Pattern

Shareholding Pattern (FY 2025)
  • Promoters 33.19%
  • DII 23.22%
  • FII 18.28%
  • Public 22.89%
  • Others 2.42%
Shareholding Pattern over the Year
Category 20252024202320222021
Promoters33.19%33.50%33.80%34.00%34.41%
DII23.22%22.90%22.50%22.10%21.80%
FII18.28%18.00%17.60%17.20%16.90%
Public22.89%23.10%23.50%24.00%24.20%
Others2.42%2.50%2.60%2.70%2.69%
Subsidiaries Company (6)
TAYO ROLLS LIMITED
54.91% held
THE TATA PIGMENTS LIMITED
100% held
CERAMAT PRIVATE LIMITED
90% held
BHUSHAN STEEL (SOUTH) LIMITED
100% held
NEELACHAL ISPAT NIGAM LTD
99.68% held
TATA STEEL DOWNSTREAM PRODUCTS LIMITED
100% held

EPFO Establishments (1)

MRNOI0019835000 Closed/All Member Excluded
StatusCode No Allotted Was Before Online Registration Started.
ActivityPaper
StateUttar Pradesh
Coverage07-JUN-1995

Current Directors (11)

G
Managing Director | Since 1998-10-12
D
Director | Since 2020-08-14
B
Director | Since 2009-08-14
V
CFO | Since 2017-11-16
S
Director | Since 2019-04-01
A
CFO | Since 2025-05-27

Charges Overview

Bank Of India : 230.00 cr
The Hongkong And Shanghai Banking Corporation Limited : 200.00 cr
Central Bank Of India : 150.00 cr
Axis Bank Limited : 75.00 cr
Open Charges: 1 Satisfied Charges: 13
Open -150.00 cr
Satisfied 1,040.00 cr
LenderAmountStatus
Bank Of India
Creation Date: 29 Jul 2009
60.00 cr Closed
Axis Bank Limited
Creation Date: 18 Jun 2009
75.00 cr Closed
Central Bank Of India
Creation Date: 16 Jan 2009
150.00 cr Closed

Business Activity

Activity GroupDescriptionTurnover %
Manufacturing-100.00

Flagged By Authority

Regulatory and exchange flags (preview)

Frequently Asked Questions about Glenmarkpharma
What is CIN of Glenmarkpharma?
The Corporate Identification Number (CIN) for Glenmarkpharma is L24299MH1977PLC019982. CIN is a distinct identification code allotted by the Registrar of Companies (ROC) under the Ministry of Corporate Affairs (MCA). The company registration number is 019982 as per MCA.
When was Glenmarkpharma incorporated?
Glenmarkpharma was incorporated 48 years 6 months ago on 18 Nov 1977.
What is paid-up capital and authorised share capital of Glenmarkpharma?
The paid-up capital of Glenmarkpharma is ₹ 282,200,809.00 and authorised share capital is ₹ 2,770,000,000.00.
Who are the current board members and directors of Glenmarkpharma?
Currently 11 directors are associated with Glenmarkpharma: Glenn Mario Saldanha, Dipankar Bhattacharjee, Blanche Saldanha Elizabeth, V S Mani, Sona Saira Ramasastry, Anurag Mantri, Pradeep Kumar Sinha, Harish Vinayak Kuber, Cherylann Maria Pinto, Vijayalakshmi Rajaram Iyer, Patricia Susan Andrews.
  • Glenn Mario Saldanha
  • Dipankar Bhattacharjee
  • Blanche Saldanha Elizabeth
  • V S Mani
  • Sona Saira Ramasastry
  • Anurag Mantri
  • Pradeep Kumar Sinha
  • Harish Vinayak Kuber
  • Cherylann Maria Pinto
  • Vijayalakshmi Rajaram Iyer
  • Patricia Susan Andrews
What is the registered address of Glenmarkpharma?
As per Ministry of Corporate Affairs (MCA), the registered address of Glenmarkpharma is B-2Mahalaxmi Chambers22 Bhulabhai Desai Road Mahalaxmi, Mumbai, Maharashtra, 400026, India.
Is Glenmarkpharma registered with any stock exchange in India?
Yes, Glenmarkpharma is registered on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE): GLENMARK.
What is the official website of Glenmarkpharma?
The official website of Glenmarkpharma is https://glenmarkpharma.com.
What is the ROC code of Glenmarkpharma?
Glenmarkpharma ROC code is Roc Mumbai.
What is the company classification of Glenmarkpharma?
Glenmarkpharma is classified as Public Limited Indian Non-Government Company.
Glenmarkpharma - is it listed or unlisted?
Glenmarkpharma is a Listed company.
Does Glenmarkpharma have subsidiaries?
Glenmarkpharma has 1 subsidiary record(s) in available group structure data. See the Ownership section for group structure detail.
What is the current status of Glenmarkpharma?
Glenmarkpharma is currently Active and registered in Mumbai, Maharashtra, India.
What industry or business activity is Glenmarkpharma associated with?
Glenmarkpharma lists activity aligned with: Pharma - Drug Formulation & Development - Manufacturing. See the Overview and Competition sections for fuller industry context.
How many employees does Glenmarkpharma have?
Available records indicate roughly 13,458 employees for Glenmarkpharma. Confirm against filings and EPFO-related signals on the profile where shown.
Does Glenmarkpharma have GST registrations on file?
Glenmarkpharma shows 12 active GST registration signal(s) in compliance overview data. Open the Compliance tab for GSTIN and filing context when your plan allows.
Where can I see charges and lenders for Glenmarkpharma?
Use the Charges tab for MCA charge filings, charge holders, and open versus satisfied charges for Glenmarkpharma.
How do I contact Glenmarkpharma?
Use the official website at https://glenmarkpharma.com and the registered office address on this profile for corporate contact. Infyner does not publish personal customer-care numbers unless they appear in sourced company records.
What is the turnover or revenue of Glenmarkpharma?
Turnover and revenue appear in filed financial statements when available. Open the Financial tab on this profile for revenue, profit or loss, balance sheet metrics, and related MCA filings - not headline estimates.
How can I get the financial details of Glenmarkpharma?
You can view revenue, profit or loss, balance sheet metrics, and related filings on the Financial tab of this company profile.
What is the net worth of Glenmarkpharma (last filed snapshot)?
As per the latest financial snapshot on file for FY 2025, net worth is about ₹ 24,503.96 Cr. Verify figures on the Financial tab and supporting filings.